Live Case: Srini Potluri, MD and Sameh Sayfo, MD Imaging Guided Complex PCI

Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of Intravascualr Imaging and MRI Core Laboratories at Cardiovascular Research Foundation In New York. She is an expert of intravascular imging (Intraascular ultrasound, Optical coherence tomography, Infrared spectroscopy) to detect vulnerable plauqe and optimize PCI.

Dr. Binita Shah was awarded her MD and MS in Clinical Investigation from NYU School of Medicine, and completed her Interventional Cardiology fellowship at NYU in 2011. Dr. Shah is Associate Director of Research for Interventional Cardiology at NYU. She is also Associate Director of Interventional Cardiology at the VA New York Harbor Healthcare System. Dr. Shah conducts clinical translational research and utilizes a multi-disciplinary approach to the treatment of CAD with a focus on optimization of the underlying inflammatory and glucometabolic milieu. She was a KL2 Scholar, recipient of the AHA Clinical Research grant, and PI of the NIH-funded Colchicine-PCI trial and ColCorona-US study. Dr. Shah is currently PI of the NIH-funded CLEAR SYNERGY Biospecimen Substudy. Dr. Shah serves on national committees through SCAI, AHA, and ACC, is Associate Editor for Circulation Cardiovascular Intervention, and serves on the SCAI Board of Trustees

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.